Please use this identifier to cite or link to this item:
https://hdl.handle.net/10419/55927
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sturm, Andreas | en |
dc.contributor.author | Dowling, Michael J. | en |
dc.contributor.author | Röder, Klaus | en |
dc.date.accessioned | 2012-03-15T14:03:40Z | - |
dc.date.available | 2012-03-15T14:03:40Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | |aJournal of Entrepreneurial Finance, JEF|c1551-9570|v12|h2|nThe Academy of Entrepreneurial Finance (AEF)|lMontrose, CA|y2007|p23-53 | en |
dc.identifier.uri | http://hdl.handle.net/10419/55927 | - |
dc.description.abstract | We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, separating it from the asset price movements caused by other factors such as market and industry effects. The results are then used to validate the model developed in this article as an alternative to the explanations given by Sharma and Lacey (2004). The results of this study support the Efficient Market Hypothesis, i.e. that the market reacts to the new information quickly and clearly. | en |
dc.language.iso | eng | en |
dc.publisher | |aThe Academy of Entrepreneurial Finance (AEF) |cMontrose, CA | en |
dc.subject.ddc | 650 | en |
dc.title | FDA drug approvals: Time Is money! | - |
dc.type | Article | en |
dc.identifier.ppn | 663299608 | en |
dc.rights | http://www.econstor.eu/dspace/Nutzungsbedingungen | en |
econstor.citation.journaltitle | Journal of Entrepreneurial Finance, JEF | en |
econstor.citation.issn | 1551-9570 | en |
econstor.citation.volume | 12 | en |
econstor.citation.issue | 2 | en |
econstor.citation.publisher | The Academy of Entrepreneurial Finance (AEF) | en |
econstor.citation.publisherplace | Montrose, CA | en |
econstor.citation.year | 2007 | en |
econstor.citation.startpage | 23 | en |
econstor.citation.endpage | 53 | en |
Files in This Item:
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.